Determinants of Ocular Surface Biogeography

眼表生物地理学的决定因素

基本信息

  • 批准号:
    10596574
  • 负责人:
  • 金额:
    $ 42.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

The wet epithelial surface of the eye is chemically, immunologically and as a result, ecologically unique and profoundly different from the keratinized surfaces of the surrounding adnexa. Although it is intuitively obvious that this would have a substantial impact on the microbes that inhabit and infect these distinct sites on the ocular landscape, we show in preliminary data that this has profound consequences for the types of methicillin resistant S. aureus (MRSA) that infect wet versus keratinized ocular epithelial tissues. The study of biogeography has been long established in zoology and botany, however only since genomics has given us the high‐resolution power to view distinctions between microbes at various anatomical sites, has it been possible to study the biogeography of the human anatomy, including the eye and surrounding tissues – and its impact on infectious diseases. We used this new biogeographical lens to view the ocular surface landscape, and in preliminary data showed for the first time, that a leading cause of multidrug resistant ocular infections at all anatomical sites, MRSA, specializes in infecting the ocular wet epithelial surface versus the keratinized epithelium of the adnexa. There is a critical gap in understanding why one MRSA lineage, CC5/USA100, is better positioned to infect the cornea and conjunctiva. As ocular surface infections are leading causes of vision loss worldwide, and CC5/USA100 MRSA represent the most highly antibiotic resistant MRSA clade, there is an urgency to understanding the drivers of MRSA biogeography for the eye. Achieving our aims will identify the precise host conditions under which selection for one MRSA lineage over another occurs, will identify the host factors contributing to this selection, and will identify the microbial factors that differentially empower CC5 strains to persist on the wet epithelium of the ocular surface as a forerunner to infection. The importance of this information is that it will provide new and critical insights that will allow eye care professionals to manage the ocular surface in a way that will reduce the likelihood of infection, by discovering biomarkers and key ocular surface defenses. Further, it will identify critical features of pathogenic MRSA lineages that now can be targeted therapeutically. Filling this critical knowledge gap will be a major advance for driving the field forward to mitigate an important global cause of vision loss.
眼睛的湿润上皮表面在化学上、免疫学上以及因此在生态学上是独特的, 与周围附件的角质化表面有很大不同。虽然直觉上很明显 这将对栖息和感染眼部这些不同部位的微生物产生重大影响, 景观,我们在初步数据中表明,这对耐甲氧西林的类型有深远的影响, S.金黄色葡萄球菌(MRSA),其感染湿的与角化的眼上皮组织。历史学的研究 早在动物学和植物学中就已经建立,然而,只是因为基因组学给了我们高分辨率的 在不同的解剖部位观察微生物之间的区别,是否有可能研究 人体解剖学的血管造影,包括眼睛和周围组织-及其对感染的影响 疾病我们使用这种新的地理透镜来观察眼表景观,在初步数据中, 首次表明,在所有解剖部位, MRSA,专门感染眼部湿润上皮表面,而不是附件的角化上皮。 在理解为什么一个MRSA谱系CC 5/USA 100更好地感染 角膜和结膜由于眼表感染是全球视力丧失的主要原因, CC 5/USA 100 MRSA代表最高度抗生素耐药的MRSA分支,迫切需要 了解眼睛MRSA细菌谱的驱动因素。实现我们的目标将确定准确的主机 一种MRSA谱系相对于另一种的选择发生的条件,将识别宿主因素 有助于这种选择,并将确定微生物因素,差异授权CC 5菌株, 持续存在于眼表面的湿润上皮上,作为感染的先导。这一点的重要性 信息是,它将提供新的和关键的见解,将允许眼科护理专业人员管理 通过发现生物标志物和关键的眼表, 地面防御此外,它将确定致病性MRSA谱系的关键特征,现在可以针对 治疗上填补这一关键的知识空白将是推动该领域向前发展的一个重大进步, 减轻全球视力丧失的重要原因。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael S Gilmore其他文献

Michael S Gilmore的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael S Gilmore', 18)}}的其他基金

The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
肠球菌独特的假设 EF1909 在内在 β-内酰胺耐药性中的作用
  • 批准号:
    10569041
  • 财政年份:
    2022
  • 资助金额:
    $ 42.5万
  • 项目类别:
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
肠球菌独特的假设 EF1909 在内在 β-内酰胺耐药性中的作用
  • 批准号:
    10464409
  • 财政年份:
    2022
  • 资助金额:
    $ 42.5万
  • 项目类别:
Determinants of Ocular Surface Biogeography
眼表生物地理学的决定因素
  • 批准号:
    10396467
  • 财政年份:
    2020
  • 资助金额:
    $ 42.5万
  • 项目类别:
New understanding of LTA as a determinant of daptomycin susceptibility in VRE E. faecium
对 LTA 作为 VRE 屎肠球菌达托霉素敏感性决定因素的新认识
  • 批准号:
    9926227
  • 财政年份:
    2019
  • 资助金额:
    $ 42.5万
  • 项目类别:
New understanding of LTA as a determinant of daptomycin susceptibility in VRE E. faecium
对 LTA 作为 VRE 屎肠球菌达托霉素敏感性决定因素的新认识
  • 批准号:
    9810471
  • 财政年份:
    2019
  • 资助金额:
    $ 42.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9151285
  • 财政年份:
    2016
  • 资助金额:
    $ 42.5万
  • 项目类别:
Subproject 3 New Approaches to Treatment and Prevention of Antibiotic Resistant Infection
子项目3 治疗和预防抗生素耐药感染的新方法
  • 批准号:
    9151288
  • 财政年份:
    2016
  • 资助金额:
    $ 42.5万
  • 项目类别:
Molecular Basis for Ocular Surface Tropism in Conjunctivitis
结膜炎眼表向性的分子基础
  • 批准号:
    9264533
  • 财政年份:
    2014
  • 资助金额:
    $ 42.5万
  • 项目类别:
Molecular Basis for Ocular Surface Tropism in Conjunctivitis
结膜炎眼表向性的分子基础
  • 批准号:
    8670576
  • 财政年份:
    2014
  • 资助金额:
    $ 42.5万
  • 项目类别:
Identification of infection-critical S. aureus traits by TnSeq
通过 TnSeq 鉴定感染关键的金黄色葡萄球菌性状
  • 批准号:
    8660637
  • 财政年份:
    2013
  • 资助金额:
    $ 42.5万
  • 项目类别:

相似海外基金

Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
  • 批准号:
    EP/Y031067/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.5万
  • 项目类别:
    Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307222
  • 财政年份:
    2024
  • 资助金额:
    $ 42.5万
  • 项目类别:
    Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
  • 批准号:
    502587
  • 财政年份:
    2024
  • 资助金额:
    $ 42.5万
  • 项目类别:
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307223
  • 财政年份:
    2024
  • 资助金额:
    $ 42.5万
  • 项目类别:
    Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
  • 批准号:
    MR/Y013131/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.5万
  • 项目类别:
    Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
  • 批准号:
    MR/X009580/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.5万
  • 项目类别:
    Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
  • 批准号:
    2340818
  • 财政年份:
    2024
  • 资助金额:
    $ 42.5万
  • 项目类别:
    Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
  • 批准号:
    480022
  • 财政年份:
    2023
  • 资助金额:
    $ 42.5万
  • 项目类别:
    Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
  • 批准号:
    BB/X010473/1
  • 财政年份:
    2023
  • 资助金额:
    $ 42.5万
  • 项目类别:
    Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
  • 批准号:
    10670613
  • 财政年份:
    2023
  • 资助金额:
    $ 42.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了